Is cyclosporine a good option for the treatment of subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic syndrome?

Indian J Dermatol Venereol Leprol. 2019 Nov-Dec;85(6):656-659. doi: 10.4103/ijdvl.IJDVL_747_18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Cyclosporine / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lymphohistiocytosis, Hemophagocytic / complications
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphoma, T-Cell / complications
  • Lymphoma, T-Cell / drug therapy*
  • Lymphoma, T-Cell / pathology
  • Panniculitis / complications
  • Panniculitis / drug therapy*
  • Panniculitis / pathology
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*

Substances

  • Immunosuppressive Agents
  • Cyclosporine

Supplementary concepts

  • Subcutaneous panniculitis-like T-cell lymphoma